Dr Jeffrey W Watson, DPM | |
2534 W 15th Ave, Emporia, KS 66801-6102 | |
(620) 343-6011 | |
(620) 343-6353 |
Full Name | Dr Jeffrey W Watson |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 44 Years |
Location | 2534 W 15th Ave, Emporia, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821108036 | NPI | - | NPPES |
100094290C | Medicaid | KS | |
006713 | Other | KS | BLUE CROSS BLUE SHIELD OF |
100094290A | Medicaid | KS | |
480000830 | Other | KS | PALMETTO GBA-RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 12-00179 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey W Watson, DPM 2534 W 15th Ave, Emporia, KS 66801-6102 Ph: (620) 343-6011 | Dr Jeffrey W Watson, DPM 2534 W 15th Ave, Emporia, KS 66801-6102 Ph: (620) 343-6011 |
News Archive
Retail health clinics are reevaluating their offerings. The Wall Street Journal reports: "Retail health clinics are adding treatments for chronic diseases such as asthma to their repertoire, hoping to find steadier revenue, but putting the clinics into greater competition with doctors' groups and hospitals."
The number of adverse reactions reported by UK doctors to the antidepressant paroxetine - often know by its brand name Seroxat - rose by 61 per cent after three editions of the BBC's award-winning current affairs programme Panorama explored increasing concerns about the drug.
German researchers determined that concentrations of the sex hormones, testosterone in men and estrogen in women, may have a positive effect on the regenerative potential of cartilage tissue. The study suggests hormone replacement in the joint fluid of men and women might be beneficial in treating late stages of human osteoarthritis by regenerating damaged tissue.
Halyard Health Inc., formerly Kimberly-Clark Health Care, today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR). Under the contract, BARDA will fund research by Halyard to develop a one-of-a-kind, high-speed machine to manufacture N95 Filtering Facepiece Respirators (FFRs) that can be used during a pandemic.
VillageReach, the Seattle-based social enterprise that increases access to healthcare for remote, last mile communities in low-income countries, today announced a $5.6 million program to strengthen the national health system in Mozambique. Contributions for the six-year program total $1.2 million to date.
› Verified 9 days ago